Nesiritide in congestive heart failure associated with acute coronary syndromes: a pilot study of safety and efficacy
- 1 April 2004
- journal article
- clinical trial
- Published by Elsevier BV in Journal of Cardiac Failure
- Vol. 10 (2), 120-125
- https://doi.org/10.1016/j.cardfail.2003.08.012
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Retrospective Review: The Incidence of Non-ST Segment Elevation MI in Emergency Department Patients Presenting With Decompensated Heart FailureCongestive Heart Failure, 2003
- Effect of nesiritide (B-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure: The PRECEDENT studyAmerican Heart Journal, 2002
- Intravenous Nesiritide vs Nitroglycerin for Treatment of Decompensated Congestive Heart FailureJAMA, 2002
- Nesiritide for the treatment of decompensated heart failureJournal of Cardiac Failure, 2001
- Inotropic effect of human b-type natriuretic peptide in the failing human heartJournal of Cardiac Failure, 1998
- ISIS-4: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58 050 patients with suspected acute myocardial infarctionThe Lancet, 1995
- Effect of brain (B-type) natriuretic peptide on coronary artery diameter and coronary hemodynamic variables in humans: Comparison with effects on systemic hemodynamic variablesJournal of the American College of Cardiology, 1995
- Biochemical mechanism of organic nitrate actionThe American Journal of Cardiology, 1992
- Expression of brain natriuretic peptide gene in human heart. Production in the ventricle.Hypertension, 1991
- Nitroglycerin causes vasodilatation within ischaemic myocardiumCardiovascular Research, 1980